HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Selective ablation of slow conduction pathway in a patient with atrioventricular nodal reentrant tachycardia].

Abstract
In a 42-year female with paroxysmal atrioventricular nodal reentrant tachycardia of the type I (slow/fast) verapamil did not prevent it. Verapamil injections terminated tachycardia but marked hypotonia followed. Electrophysiologic study revealed dual conduction pathway within the atrioventricular node that made the substrate for reentrant tachycardia. An effective refractory period od the slow conduction pathway in antegrade direction was less than 220 msec. An effective refractory period of the fast pathway in antegrade and retrograde directions was 300 msec. Radiofrequency current ablation was performed at the site of slow pathway morphology electrogram recording. A single application of the radiofrequency current that lasted 40 sec. producing the maximum 60C successively ablated the slow pathway. Follow-up electrophysiologic study before and after atropine administration proved the success of this procedure. No other heart structures were damaged. A 4-month follow-up period did not show tachycardia.
AuthorsE Marcisz-Szufladowicz, F Walczak, E Kozluk, Z Jedynak
JournalPolski tygodnik lekarski (Warsaw, Poland : 1960) (Pol Tyg Lek) 1993 Jan 18-25 Vol. 48 Issue 3-4 Pg. 85-6 ISSN: 0032-3756 [Print] Poland
Vernacular TitleCelowana ablacja drogi o wolnym przewodzeniu u chorej z nawrotnym czestoskurczem wezłowym.
PMID8361897 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Adult
  • Electrocardiography
  • Female
  • Heart Conduction System (surgery)
  • Humans
  • Tachycardia, Atrioventricular Nodal Reentry (diagnosis, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: